OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comprehensive Metabolomic Analysis of Lung Cancer Patients Treated with Fu Zheng Fang
Yongjuan Ding, Juan Lv, Yujiao Hua
Current Pharmaceutical Analysis (2022) Vol. 18, Iss. 9, pp. 881-891
Closed Access | Times Cited: 7
Yongjuan Ding, Juan Lv, Yujiao Hua
Current Pharmaceutical Analysis (2022) Vol. 18, Iss. 9, pp. 881-891
Closed Access | Times Cited: 7
Showing 7 citing articles:
A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
Jie Fu, Yi‐Dan Yan, Xu Wan, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Jie Fu, Yi‐Dan Yan, Xu Wan, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
A nicotinamide metabolism-related gene signature for predicting immunotherapy response and prognosis in lung adenocarcinoma patients
Meng Wang, Li Wei, Fang Zhou, et al.
PeerJ (2025) Vol. 13, pp. e18991-e18991
Open Access
Meng Wang, Li Wei, Fang Zhou, et al.
PeerJ (2025) Vol. 13, pp. e18991-e18991
Open Access
Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer
Zhixuan Wu, Haoyi Xiang, Xiaowu Wang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Zhixuan Wu, Haoyi Xiang, Xiaowu Wang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Prominin 2 knockdown inhibits the growth, migration, and invasion of non-small cell lung cancer cells by repressing phosphatidylinositol 3 kinase/protein kinase B pathway
Biao He, Zhiyuan Chen, Liang Zhong, et al.
CytoJournal (2025) Vol. 22, pp. 21-21
Open Access
Biao He, Zhiyuan Chen, Liang Zhong, et al.
CytoJournal (2025) Vol. 22, pp. 21-21
Open Access
Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma
Zhen Chen, Yongjun Zhang
PeerJ (2025) Vol. 13, pp. e19121-e19121
Open Access
Zhen Chen, Yongjun Zhang
PeerJ (2025) Vol. 13, pp. e19121-e19121
Open Access
Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2
Shiyu Cao, H. Li, Xiaoyan Ye, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Shiyu Cao, H. Li, Xiaoyan Ye, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Comprehensive analysis of transcriptomics and radiomics revealed the potential of TEDC2 as a diagnostic marker for lung adenocarcinoma
Qian Huang, Peng Zhang, Zheng Guo, et al.
PeerJ (2024) Vol. 12, pp. e18310-e18310
Open Access
Qian Huang, Peng Zhang, Zheng Guo, et al.
PeerJ (2024) Vol. 12, pp. e18310-e18310
Open Access
